CI monthly performance report
Monthly CI research: returns, drawdown, relative strength, seasonality, and key stats.
CI monthly report
—
Key takeaways
- Cigna (CI) closed August 2026 at $270.50, down 3.06% for the month and −0.09% over the trailing 12 months.
- Year-to-date, CI is −1.72%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −3.28% versus its 200-day moving average ($279.66), a cautious technical signal.
- Over the past three years, CI has underperformed the S&P 500 by −77.90%, with a relative strength index reading of 54.3.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Cigna ended August 2026 at $270.50, posting a monthly return of −3.06%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −6.11%.
The current quarter stands at −1.27% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −3.28% versus the 200-day moving average ($279.66).
Year-to-date, CI is −1.72% against SPY +12.89%, a gap of −14.60%. The stock is currently −14.25% below its 52-week high, with maximum 3-year drawdown at −33.38%.
| Period | CI | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.30% | −0.20% | −1.10% |
| 1 Week | −10.15% | +3.90% | −14.06% |
| 1 Month | −3.06% | +3.05% | −6.11% |
| 3 Months | −6.91% | +7.11% | −14.02% |
| 6 Months | −0.38% | +10.70% | −11.08% |
| YTD | −1.72% | +12.89% | −14.60% |
| 12 Months | −0.09% | +22.58% | −22.67% |
| 3 Years | −5.61% | +72.29% | −77.90% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2025 | +14.23% |
| #2 | Dec 2023 | +13.45% |
| #3 | Jun 2023 | +12.75% |
| #4 | Aug 2025 | +11.64% |
| #5 | Feb 2024 | +10.71% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2025 | −19.44% |
| #2 | Dec 2024 | −17.86% |
| #3 | Oct 2025 | −15.13% |
| #4 | Nov 2023 | −14.58% |
| #5 | Oct 2024 | −9.01% |
| Quarter | Return |
|---|---|
| Q2 2025 | +0.42% |
| Q3 2025 | −13.95% |
| Q4 2025 | −3.70% |
| Q1 2026 | −2.56% |
| Q2 2026 | +4.63% |
| Q3 2026 (QTD) | −1.27% |
| Year | Return |
|---|---|
| 2023 | −9.08% |
| 2024 | −1.57% |
| 2025 | −0.87% |
| 2026 | +0.66% |
| Metric | Value |
|---|---|
| 52-Week High | $315.47 (2025-10-03) |
| 52-Week Low | $239.51 (2025-11-03) |
| Current Price | $270.50 |
| 200-Day Moving Average | $279.66 |
| Price vs 200DMA | −3.28% |
| 3-Year Maximum Drawdown | −33.38% (2025-10-31) |
| Current Drawdown from 52W High | −14.25% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 54.3 |
| 3-Year Excess Return vs S&P 500 | −77.90% |
| RS Peak | 114.3 (Nov 2023) |
| RS Trough | 54.3 (Aug 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CI's return for this report period?
CI returned −3.06% in the latest monthly window ending 2026-08-05.
Has CI outperformed SPY year to date?
YTD CI: −1.72% vs SPY: +12.89%.
What is CI's 12-month return?
−0.09% over the trailing 12 months.
Is CI above or below its 200-day moving average?
Price is −3.28% versus 200DMA ($279.66).
What is the maximum drawdown in the 3-year window?
−33.38% on 2025-10-31.